COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:CRI - FR0000130692 - Common Stock
10 EUR
-0.04 (-0.4%)
We assign a fundamental rating of 3 out of 10 to CRI. CRI was compared to 14 industry peers in the Industrial Conglomerates industry. Both the profitability and financial health of CRI have multiple concerns. While showing a medium growth rate, CRI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
CRI had positive earnings in the past year.
In the past year CRI had a positive cash flow from operations.
Of the past 5 years CRI 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: CRI reported negative operating cash flow in multiple years.
1.2 Ratios
CRI has a worse Return On Assets (0.28%) than 66.67% of its industry peers.
The Return On Equity of CRI (1.03%) is worse than 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.17%, CRI is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CRI is below the industry average of 6.77%.
The 3 year average ROIC (4.66%) for CRI is below the current ROIC(5.17%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROIC | 5.17% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.66%
ROIC(5y)5.49%
1.3 Margins
The Profit Margin of CRI (0.37%) is worse than 66.67% of its industry peers.
CRI's Profit Margin has declined in the last couple of years.
CRI has a Operating Margin (6.43%) which is comparable to the rest of the industry.
CRI's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 28.51%, CRI is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.43% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% |
OM growth 3Y1.6%
OM growth 5Y1.35%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRI is destroying value.
The number of shares outstanding for CRI remains at a similar level compared to 1 year ago.
CRI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CRI has been reduced compared to a year ago.
2.2 Solvency
CRI has an Altman-Z score of 1.23. This is a bad value and indicates that CRI is not financially healthy and even has some risk of bankruptcy.
CRI has a Altman-Z score of 1.23. This is amonst the worse of the industry: CRI underperforms 80.00% of its industry peers.
The Debt to FCF ratio of CRI is 136.13, which is on the high side as it means it would take CRI, 136.13 years of fcf income to pay off all of its debts.
CRI has a worse Debt to FCF ratio (136.13) than 66.67% of its industry peers.
CRI has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.38, CRI is doing worse than 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 136.13 | ||
| Altman-Z | 1.23 |
ROIC/WACC0.85
WACC6.05%
2.3 Liquidity
A Current Ratio of 1.30 indicates that CRI should not have too much problems paying its short term obligations.
CRI has a Current ratio of 1.30. This is amonst the worse of the industry: CRI underperforms 86.67% of its industry peers.
A Quick Ratio of 0.85 indicates that CRI may have some problems paying its short term obligations.
With a Quick ratio value of 0.85, CRI is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 152.00%, which is quite impressive.
CRI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.59% yearly.
Looking at the last year, CRI shows a small growth in Revenue. The Revenue has grown by 6.67% in the last year.
CRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.10% yearly.
EPS 1Y (TTM)152%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-142.86%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
The Earnings Per Share is expected to grow by 32.19% on average over the next years. This is a very strong growth
Based on estimates for the next years, CRI will show a small growth in Revenue. The Revenue will grow by 3.45% on average per year.
EPS Next Y7.79%
EPS Next 2Y41.87%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 76.92 indicates a quite expensive valuation of CRI.
Based on the Price/Earnings ratio, CRI is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
CRI is valuated expensively when we compare the Price/Earnings ratio to 26.92, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.25, which indicates a very decent valuation of CRI.
CRI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CRI is cheaper than 80.00% of the companies in the same industry.
CRI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 76.92 | ||
| Fwd PE | 11.25 |
4.2 Price Multiples
CRI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRI is cheaper than 73.33% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CRI is valued a bit more expensive than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 80.29 | ||
| EV/EBITDA | 7.22 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CRI does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CRI's earnings are expected to grow with 32.19% in the coming years.
PEG (NY)9.87
PEG (5Y)N/A
EPS Next 2Y41.87%
EPS Next 3Y32.19%
5. Dividend
5.1 Amount
CRI has a Yearly Dividend Yield of 1.30%.
CRI's Dividend Yield is slightly below the industry average, which is at 3.20.
Compared to the average S&P500 Dividend Yield of 2.00, CRI is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.3% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
118.52% of the earnings are spent on dividend by CRI. This is not a sustainable payout ratio.
DP118.52%
EPS Next 2Y41.87%
EPS Next 3Y32.19%
EPA:CRI (12/24/2025, 7:00:00 PM)
10
-0.04 (-0.4%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners5.46%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap248.90M
Revenue(TTM)727.50M
Net Income(TTM)2.70M
Analysts75
Price Target11.56 (15.6%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.3% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP118.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.85%
PT rev (3m)-11.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-26.51%
EPS NY rev (3m)-26.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.44%
Revenue NY rev (3m)-2.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 76.92 | ||
| Fwd PE | 11.25 | ||
| P/S | 0.34 | ||
| P/FCF | 80.29 | ||
| P/OCF | 10.37 | ||
| P/B | 0.95 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.22 |
EPS(TTM)0.13
EY1.3%
EPS(NY)0.89
Fwd EY8.89%
FCF(TTM)0.12
FCFY1.25%
OCF(TTM)0.96
OCFY9.64%
SpS29.23
BVpS10.49
TBVpS-1.49
PEG (NY)9.87
PEG (5Y)N/A
Graham Number5.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROCE | 7.06% | ||
| ROIC | 5.17% | ||
| ROICexc | 6.16% | ||
| ROICexgc | 13.23% | ||
| OM | 6.43% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% | ||
| FCFM | 0.43% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.66%
ROIC(5y)5.49%
ROICexc(3y)5.71%
ROICexc(5y)7.48%
ROICexgc(3y)13.23%
ROICexgc(5y)17.05%
ROCE(3y)6.38%
ROCE(5y)7.54%
ROICexgc growth 3Y-6.07%
ROICexgc growth 5Y2.64%
ROICexc growth 3Y-7.28%
ROICexc growth 5Y-2.63%
OM growth 3Y1.6%
OM growth 5Y1.35%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 136.13 | ||
| Debt/EBITDA | 4.63 | ||
| Cap/Depr | 67.42% | ||
| Cap/Sales | 2.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.85% | ||
| Profit Quality | 114.82% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 1.23 |
F-Score7
WACC6.05%
ROIC/WACC0.85
Cap/Depr(3y)58.97%
Cap/Depr(5y)54.86%
Cap/Sales(3y)2.5%
Cap/Sales(5y)2.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-142.86%
EPS Next Y7.79%
EPS Next 2Y41.87%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
EBIT growth 1Y58.11%
EBIT growth 3Y1.28%
EBIT growth 5Y4.5%
EBIT Next Year104.23%
EBIT Next 3Y38.23%
EBIT Next 5YN/A
FCF growth 1Y108.81%
FCF growth 3Y-17.63%
FCF growth 5Y170.57%
OCF growth 1Y245.46%
OCF growth 3Y-11.49%
OCF growth 5Y12.03%
COMPAGNIE CHARGEURS INVEST / CRI.PA FAQ
What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.
Can you provide the valuation status for COMPAGNIE CHARGEURS INVEST?
ChartMill assigns a valuation rating of 3 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Overvalued.
What is the profitability of CRI stock?
COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.
What is the financial health of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.
Can you provide the expected EPS growth for CRI stock?
The Earnings per Share (EPS) of COMPAGNIE CHARGEURS INVEST (CRI.PA) is expected to grow by 7.79% in the next year.